KDT Advisors’s Tenet Healthcare THC Stock Holding History

KDT Advisors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-8,000	Closed	-$1.08M	–	78
2025 Q1	$1.08M	Hold	8,000	–	–	1.58%	14
2024 Q4	$1.01M	Buy	+8,000	New	+$1.19M	1.48%	18

Other funds holding THC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

KDT Advisors's THC Position: Q2 2025 in Review

KDT Advisors sold out of Tenet Healthcare (THC) in Q2 2025, closing a stake of 8,000 shares — an estimated $1.08M sold.

KDT Advisors first reported a position in THC in Q4 2024 and held it in 2 quarters. The position peaked at $1.08M in Q1 2025. 626 funds tracked by Wall St. Rank hold THC as of Q2 2025.

KDT Advisors reported no remaining Tenet Healthcare position as of Q2 2025 after selling out during the quarter.
KDT Advisors sold 8,000 Tenet Healthcare shares in Q2 2025, an estimated $1.08M.
KDT Advisors first reported a position in Tenet Healthcare in Q4 2024 and held it in 2 quarters.
KDT Advisors's Tenet Healthcare position peaked at $1.08M in Q1 2025.
626 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2025.

Based on KDT Advisors's 13F filing for Q2 2025, filed 5 Aug 2025.